MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to ...
Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward and Positions Oramed as a Significant Shareholder NEW YORK, Jan. 13, 2026 /PRNewswire/ -- Oramed ...
Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential Up to $47 million strategic investment from Oramed and another investor is ...
Lifeward Ltd. (Nasdaq: LFWD) ('Lifeward” or the 'Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced ...
Lifeward Ltd. and MYOLYN, Inc. have announced the expansion of their exclusive contract to enhance patient access to the MyoCycle FES Cycling Therapy System for home use. This collaboration aims to ...
Lifeward Ltd. reported its financial results for the first quarter of 2025, highlighting a continuing build-up of opportunities for the ReWalk exoskeleton with over 120 qualified leads. The company's ...
HUDSON, Mass. and YOKNEAM ILLIT, Israel - Lifeward Ltd. (NASDAQ:LFWD) announced today that its shareholders approved the issuance of ordinary shares in connection with its strategic partnership with ...
Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results